Evaluation of the Scalp Skin Care Effects of Premium Revitalizing Elixir and Topical 5% Minoxidil

The study aims to evaluate the efficacy of two formulations on human scalp skin against established standard treatment of 5% minoxidil and base formula (placebo). A total of 40 healthy adults, aged 18 to 60 with alopecia, baldness, or self-identified with symptoms of hair thinning will be recruited and randomly assigned into four groups (n=10 for each group) receiving different formulations. Participants will use the product twice daily (once in the morning and once in the evening) for 84 days, and their scalp conditions will be assessed through skin texture tests at multiple time points. Key parameters such as sebum content, overall hair loss, hair density, scalp condition, and hair length will be measured at an interval of two weeks for a total of seven times, including baseline measurements.

Inclusion Criteria: * Healthy adults of any gender from the age of 18 to 60 years (inclusive). * Having symptoms of alopecia, baldness, or self-identified with hair thinning. * Absence of chronic diseases, major illnesses, or allergies. * Major illnesses include cancer, post-stroke disorders, paralysis, acute myocardial infarction, coronary artery bypass surgery, end-stage renal disease, and major organ transplant or hematopoietic stem cell transplant Exclusion Criteria: * Currently taking any medication or using any scalp care products * Pregnant or breastfeeding * Chronic diseases, significant illnesses, or allergic constitutions * Currently using scalp care products * Students or employees affiliated with the principal investigator, * Individuals with scalp wounds * Participated in cosmetic product testing * Undergone scalp aesthetic treatments within the past three months.